Direxion Daily Semiconductor Bull 3x Shares ETF
SOXL
VanEck Semiconductor ETF
SMH
Invesco Solar ETF
TAN
4
Direxion Daily Energy Bull 2X Shares ETF
ERX
5
The Technology Select Sector SPDR® Fund
XLK
US Stock MarketDetailed Quotes
Clene (CLNN)
- 7.140
- +0.090+1.28%
Close May 15 16:00 ET
- 6.810
- -0.330-4.62%
Post 20:01 ET
91.24MMarket Cap-2.20P/E (TTM)
7.368High6.710Low151.60KVolume6.790Open7.050Prev Close1.07MTurnover1.47%Turnover RatioLossP/E (Static)12.78MShares13.50052wk High-4.85P/B73.74MFloat Cap2.28052wk Low--Dividend TTM10.33MShs Float356.400Historical High--Div Yield TTM9.33%Range %2.280Historical Low7.025Avg Price1Lot Size
CLNN Stock Chart
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
CLNN Orderflow
Unit: --
CLNN Orderflow Trend
IntradayDayWeekMonth
No Data
Clene (CLNN) News
Analysts Offer Insights on Consumer Goods Companies: Laird Superfood (LSF) and Clene (CLNN)
JonesTrading Maintains Clene(CLNN.US) With Buy Rating, Maintains Target Price $30
Maxim Group Maintains Clene(CLNN.US) With Buy Rating, Maintains Target Price $20
A Quick Look at Today's Ratings for Clene(CLNN.US), With a Forecast Between $30 to $50
Clene (CLNN) Gets a Buy From JonesTrading
Roth Says FDA Approving Clene's ALS Treatment NDA a 'Long Shot'
Clene (CLNN) Stock Forum
$Clene (CLNN.US)$
Clene Announces $7 Million Underwritten Offering of Common Stock
by Globe Newswire
Follow
SALT LAKE CITY, May 05, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ:CLNN) (along with its subsidiaries, "Clene" or the "Company") and its wholly owned subsidiary, Clene Nanomedicine, Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), t...
Clene Announces $7 Million Underwritten Offering of Common Stock
by Globe Newswire
Follow
SALT LAKE CITY, May 05, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ:CLNN) (along with its subsidiaries, "Clene" or the "Company") and its wholly owned subsidiary, Clene Nanomedicine, Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), t...
1
2
$Clene (CLNN.US)$ can it retrace 9.7
$Clene (CLNN.US)$ can go back to 8usd++?
$Clene (CLNN.US)$ 10.3?
2
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)
105911651 : bad news??
DrJaguar8 OP 105911651 : Yes dilution